Giving sight to the developing world

Article

OTE's Victoria Farrell interviews Cambodian paediatric ophthalmologist Phara Khauv to find out how an ORBIS initiative has impacted his practice in a vastly underserved country.

Key Points

Preventable blindness still affects an unacceptably high proportion of the world's population. The World Health Organization estimates that 28 million of the world's 37 million blind suffer from preventable blindness: that's a staggering 75.7% of the world's total population of blind people. The vast majority of the needlessly blind - 90% in fact - live in the developing world.

In 1982, a non-profit organization, ORBIS International was established. The goal of the organization is to increase access to vision care services in these countries, with the goal of eventually eliminating preventable blindness.

The fellowship programme

In addition to the training programmes and the services provided by the Flying Eye Hospital, ORBIS also, in collaboration with its partner FedEx, offers fellowships to ophthalmologists from developing regions.














The programme was launched in 2006; three fellows have since been named and have undertaken courses, and a further two will be designated annually for the next five years.

Previous FedEx Fellows include Dr Thomas Cherian of the Little Flower Hospital in Kerala, India, who completed his fellowship in the areas of retina, paediatric retina and retinopathy of prematurity at Moorfields Eye Hospital, UK, and Dr Nguyen Thanh Chi of Vietnam's Da Nang Eye Hospital, who studied paediatric ophthalmology at Stanford University, US.

Recent Videos
David Yorston, FRCS, FRCOphth, discusses his EURETINA keynote lecture
Hoda Shamsnajafabadi, MSc, PhD, presents at the 2024 EURETINA meeting
Timothy L Jackson PhD, MB ChB, FRCOphth, speaks about a combination therapy for VEGF-A/C/D inhibition with sozinibercept and ranibizumab
Carl Awh, MD, FASRS, speaks about the American Society of Retina Specialists (ASRS) at EURETINA
Stefano Mercuri, MD, first author of the winning eposter “Genotype-phenotype correlations in a cohort of genetically determined Retinitis Pigmentosa (RP) Italian patients with Rho gene mutations”
Bahram Bodaghi, MD, PHD, FEBO at the 2024 EURETINA meeting
Enrico Borrelli, MD, FEBO, speaks at EURETINA
Aleksandra Rachitskaya, MD, FASRS, speaks about the Vit-Buckle Society at the 2024 EURETINA Congress.
© 2024 MJH Life Sciences

All rights reserved.